The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates

Apelseth TO, 2011, Blood Rev, 25, 113, 10.1016/j.blre.2011.01.006

10.1001/archinte.163.1.59

10.1001/archpsyc.65.7.795

van Walraven C, 2001, BMJ, 323, 655, 10.1136/bmj.323.7314.655

Opatrny L, 2008, Br J Clin Pharmacol, 66, 76, 10.1111/j.1365-2125.2008.03154.x

Wessinger S, 2006, Aliment Pharmacol Ther, 23, 937, 10.1111/j.1365-2036.2006.02859.x

10.4088/JCP.09r05786blu

van Haelst IM, 2010, Anesthesiology, 112, 631, 10.1097/ALN.0b013e3181cf8fdf

Movig KL, 2003, Arch Intern Med, 163, 2354, 10.1001/archinte.163.19.2354

Walther DJ, 2003, Cell, 115, 851, 10.1016/S0092-8674(03)01014-6

Ross SB, 1980, Psychopharmacology (Berl), 67, 1, 10.1007/BF00427588

McCloskey DJ, 2008, Transl Res, 151, 168, 10.1016/j.trsl.2007.10.004

Hergovich N, 2000, Clin Pharmacol Ther, 68, 435, 10.1067/mcp.2000.110456

Hervig T, 1990, Clin Chem, 36, 28, 10.1093/clinchem/36.1.28

Hervig TA, 1996, Platelets, 7, 53, 10.3109/09537109609079510

Hervig TA, 1996, Platelets, 7, 47, 10.3109/09537109609079509

Reikvam H, 2009, Transfus Apher Sci, 40, 119, 10.1016/j.transci.2009.01.019

Slichter SJ, 2010, Transfusion, 50, 2199, 10.1111/j.1537-2995.2010.02669.x

Kotzailias N, 2006, J Clin Pharmacol, 46, 468, 10.1177/0091270006286432

Abdelmalik N, 2008, J Thromb Haemost, 6, 2168, 10.1111/j.1538-7836.2008.03196.x

10.1016/j.amjmed.2005.11.006

Serebruany VL, 2001, Am J Cardiol, 87, 1398, 10.1016/S0002-9149(01)01562-4

10.1080/09537100400020161

Serebruany VL, 2001, Pharmacol Res, 43, 453, 10.1006/phrs.2001.0817

Musselman DL, 2000, Arch Gen Psychiatry, 57, 875, 10.1001/archpsyc.57.9.875

Morel-Kopp MC, 2009, J Thromb Haemost, 7, 573, 10.1111/j.1538-7836.2009.03278.x

Berman CL, 1986, Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest, 78, 130

10.1073/pnas.93.21.11877

Hervig T, 2004, Transfus Apher Sci, 31, 181, 10.1016/j.transci.2004.09.003